Phase 2 trial Risankizumab in Crohn’s disease
Tofacitinib for induction and maintenance therapy of Crohn’s disease: results of two phase IIb randomised placebo-controlled trials
Once- Versus Twice-daily Mesalazine to Induce Remission in Paediatric Ulcerative Colitis: A Randomised Controlled Trial
CT-P13 or infliximab originator in immune mediated inflammatory diseases
Efficacy and Safety of Oral Budesonide in Patients with Active Crohn’s Disease in Japan: A Multicenter, Double-Blind, Randomized, Parallel-Group Phase 3 Study
Adalimumab +/- azathioprine tight control vs clincal management in CD